Saied Aya, El Borolossy Radwa Maher, Ramzy Mourad Alfy, Sabri Nagwa A
Clinical Pharmacist, Al Galaa Military Medical Complex, Cairo, Egypt.
Clinical Pharmacy Department, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.
Front Pharmacol. 2022 Aug 30;13:933998. doi: 10.3389/fphar.2022.933998. eCollection 2022.
Community-acquired pneumonia (CAP) is one of the most common infectious diseases affecting the respiratory tract and is responsible for a high mortality rate in children less than 5 years of age. The mortality rate due to CAP is much higher in low/middle-income countries than in high-income countries due to malnutrition and different micronutrient deficiencies that weaken the immune system. The aim of this study was to compare the effects of zinc and vitamin A, as two elements of micronutrient agents, on the recovery rate of children suffering from CAP aged from 6 months to 5 years. The length of hospital stays was also investigated. A comparative, randomized, open-label, controlled, interventional study was carried out among children less than 5 years of age in the pediatric intensive care unit (PICU) diagnosed with CAP who were randomly divided into three groups. In addition to the standard therapy, group 1 was given zinc, group 2 was given vitamin A, and group 3 was the control group, given the standard therapy only. We compared the three groups in terms of recovery rate and hospital stay. The duration of hospitalization following zinc and vitamin A supplementation was reduced by an average of 3.21 days (95% CI: 5.01-1.41, = 0.01) and 2.43 days (95% CI: 4.29-0.57, = 0.01), respectively, compared to the control group. In addition, the two groups of vitamin A and zinc supplementation were associated with a shorter duration of pneumonic effusion ( < 0.001) in comparison to the control group. Additionally, there was no significant difference between the effects of zinc and vitamin A when compared to each other in terms of duration of hospital stay and pneumatic effusion. The administration of zinc or vitamin A supplementation proved to be useful as an add-on therapy in community-acquired pneumonia, where it reduced the length of hospital stay and the duration of pneumonic effusion in pneumonic children less than 5 years of age.
社区获得性肺炎(CAP)是影响呼吸道的最常见传染病之一,也是5岁以下儿童高死亡率的原因。由于营养不良和不同的微量营养素缺乏会削弱免疫系统,中低收入国家因CAP导致的死亡率远高于高收入国家。本研究的目的是比较作为微量营养素制剂的两种成分的锌和维生素A对6个月至5岁CAP患儿恢复率的影响。同时还调查了住院时间。在儿科重症监护病房(PICU)对5岁以下诊断为CAP的儿童进行了一项比较、随机、开放标签、对照、干预性研究,这些儿童被随机分为三组。除标准治疗外,第1组给予锌,第2组给予维生素A,第3组为对照组,仅给予标准治疗。我们比较了三组的恢复率和住院时间。与对照组相比,补充锌和维生素A后的住院时间平均分别缩短了3.21天(95%CI:5.01 - 1.41,P = 0.01)和2.43天(95%CI:4.29 - 0.57,P = 0.01)。此外,与对照组相比,补充维生素A和锌的两组患儿胸腔积液持续时间更短(P < 0.001)。此外,在住院时间和胸腔积液持续时间方面,锌和维生素A的效果相互比较时没有显著差异。事实证明,补充锌或维生素A作为社区获得性肺炎的附加治疗是有用的,它可以缩短5岁以下肺炎患儿的住院时间和胸腔积液持续时间。